Healthcare Professionals | ALK

Explore more information about allergy immunotherapy (AIT) and its long-term disease-modifying and protective effects, ALK’s movement from experience- to evidence-based AIT with clinical trials and real-world evidence, and our compliance with guidelines and sharing of clinical data. All collected for you as a healthcare professional with the purpose of improving the understanding of allergic disease, assisting prescriber decisions, and helping more people living with allergy.

We also present The Henning Løwenstein Research Award – an award to young scientists who has shown excellence within the field of allergy. 

Finally, you can read more about our work with a new allergy portal for healthcare proffesionals here.

Avatar

Allergy immunotherapy

AIT is the only treatment targeting the root cause of allergy – the immune system. Therefore, AIT has not only the capacity of improving symptoms and reducing the need for other medication, but also to induce specific tolerance beyond the duration of treatment, modify the course of the disease, and prevent development of new sensitisations and co-morbidities.

Avatar

Our data

In ALK, we focus on expanding the access to evidence-based AIT. We commit to investigating the safety and efficacy of specific treatment in controlled settings – clinical trials – and in uncontrolled settings – the real-world. This commitment offers the best of two worlds, assisting prescribers in treatment decisions and thereby helping people living with allergy.

Avatar

Henning Løwenstein Research Award

The Henning Løwenstein Research Award was established and dedicated to researcher Henning Løwenstein by ALK on his 25th anniversary of work at the company. This biennial award is given to a young scientist who has shown excellence within the field of allergy research.

New allergy portal for healthcare professionals

We are currently building a new portal for healthcare professionals, granting access to comprehensive educational resources and clinical support within the most common respiratory allergies. This will be launched in 2025 and continuously expanded with the latest medical information. Please keep posted.

In the meantime, you as a healthcare professional are welcome to register as a user and get access to The Henning Løwenstein Research Award ceremonies of 2024 and 2021 as well as educational and clinical webinars with medical experts' perspectives and panel discussions within the field of respiratory allergy.

Thank you for your patience.


Henning Løwenstein Research Award ceremonies

Watch the 2024 and 2021 Henning Løwenstein Research Award ceremonies including lectures by the winners Kelly Bruton (2024) and Julia Esser-von Bieren (2021) as well as list of previous ceremonies and winners of the award.


Medical events

Get access to interactive educational and clinical webinars in which medical experts within the field of respiratory allergy share their perspectives and discuss AIT, management of patients with respiratory allergies, and clinical practices.

Last updated: 04.06.2021